Author: Paul Cornes

Biosimilars have been in clinical use for more than 10 years, and evidence from more than 700 million patient-days’ exposure shows that approved biosimilars can be used as safely and effectively as t …

Biologics have revolutionized – and are revolutionizing – the treatment of many serious disorders. The evidence acquired from more than 10 years of clinical experience, with more than 50 biosimilar d …

Los biosimilares han estado en uso clínico durante más de 10 años, y la evidencia de exposición de más de 700 millones de días-paciente muestra que los biosimilares aprobados pueden usarse de manera …